|
The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: ---------- MicroSalt PLC - London-based provider of low-sodium salt products - Pretax loss for 2025 narrows to $3.5 million from $6.1 million in 2024, as revenue grows to $2.1 million from $750,000. IPO costs fall to nothing from $1.4 million in 2024. MicroSalt ties the improved top line to higher business-to-business sales volumes. Lowers its 2026 sales guidance to $4.5 million from previous guidance of $7.0 million in November. ‘This adjustment reflects the anticipated production timing associated with the 2027 launch schedule, rather than any change in the underlying demand outlook,’ MicroSalt notes. ‘MicroSalt’s strong progress is clearly demonstrated by the significant revenue growth achieved during 2025, momentum that we expect to accelerate further throughout 2026, 2027, and beyond. The successful reformulation work completed with several of the world’s leading snack food brands provides the company with increasing confidence in long-term revenue and commercial expansion,’ comments Chief Executive Rick Guiney. ---------- OptiBiotix Health PLC - York, England-based life science firm - Pretax loss widens to £3.9 million in 2025 from £1.9 million in 2024, as revenue grows to £1.2 million from £870,000. Administrative expenses rise 44% to £3.7 million from £2.6 million, weighing on the bottom line. Says the strong sales momentum seen in 2024 continued throughout 2025. Looking ahead, the company says it has made a ‘very strong start’ to the new financial year, noting ‘record orders’ of over £800,000 from four major partners recorded in the first four weeks of 2026, and to be delivered at approximate quarterly intervals throughout the year. ‘The company has made good progress in 2025 with growing sales, higher margins, increased gross profit and valuable assets in its holdings in PBX and SBTX with a combined market value of circa £6.5 million at the end of December 2025,’ says CEO Stephen O’Hara. ‘The Company is now focused on achieving commercial sustainability by accelerating its activities to reduce costs and improve margins whilst continuing to grow its top line in those areas showing high growth and commercialising its second-generation products.’ ---------- Majedie Investments PLC - investment trust aiming for long-term capital growth with regular dividends - Reports a net asset value total return of 4.4% for the six months ended March 31. ‘Returns over the period have been driven by a highly differentiated mix of External Managers, Direct Investments and Special Investments, built around high-conviction and non-consensus opportunities,’ says Dan Higgins, CEO at Marylebone Partners and Investment Manager of Majedie. Reports total dividends for the interim period of 4.5p, up 9.8% from 4.1p. Higgens continues: ‘As markets navigate a more uncertain path, with the oil shock and inflation threatening growth, and with policy expectations continuing to change, we believe our approach which focuses on idiosyncratic return sources and disciplined capital deployment, continues to represent a compelling proposition for long-term investors seeking inflation-beating absolute returns.’ ---------- Aberdeen Equity Income Trust PLC - London-based trust investing in UK-quoted companies - Reports NAV total return per share of 9.9% for the six months ended March 31. Notes its outperformed the FTSE All-Share Index, which returned 8.9% over the same period. NAV per share grows 6.9% to 403.75p at March 31 from 377.84p at September 30. Reports total dividends for the interim period of 11.40p, flat on-year. ‘The returns were even stronger in the five months to the end of February 2026 but moderated in March as markets reacted to the Iran war. This contributed to higher energy prices and renewed inflation concerns. This environment led to weaker performance across UK equities during the final month of the period, particularly among incomeoriented stocks,’ comments Chair Sarika Patel. Looking ahead, the company says: ‘By getting the basics right - choosing companies that are generating the cash flow to pay attractive dividends and buy back their own shares - we are also being rewarded with rising share prices which are translating into excellent capital growth for our shareholders. Whatever the geopolitics brings, we will remain alert to the opportunities as they arise, enabling us to keep the portfolio match fit.’ ---------- Colefax Group PLC - London-based designer and distributor of furnishing fabrics and wallpapers - Launches share buyback worth up to £2.5 million via a reverse bookbuild. Says broker Peel Hunt will implement the buyback, with the reverse bookbuild commencing immediately, and set to close on the afternoon of Monday next week. Explains that the primary purpose of the buyback is to reduce the company’s share capital. ---------- Frontier Developments PLC - Cambridge, England-based video game developer and publisher - Says animal management simulation game Planet Zoo 2 will launch on October 13, this year. ---------- Copyright 2026 Alliance News Ltd. All Rights Reserved.
|
